rs747398844
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6_Very_StrongBP7
The NM_198428.3(BBS9):c.270C>T(p.Thr90Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000396 in 1,591,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000055 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000038 ( 0 hom. )
Consequence
BBS9
NM_198428.3 synonymous
NM_198428.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.188
Publications
0 publications found
Genes affected
BBS9 (HGNC:30000): (Bardet-Biedl syndrome 9) This gene is downregulated by parathyroid hormone in osteoblastic cells, and therefore is thought to be involved in parathyroid hormone action in bones. The exact function of this gene has not yet been determined. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2017]
BBS9 Gene-Disease associations (from GenCC):
- Bardet-Biedl syndrome 9Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Bardet-Biedl syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 7-33155644-C-T is Benign according to our data. Variant chr7-33155644-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 263128.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.188 with no splicing effect.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BBS9 | NM_198428.3 | c.270C>T | p.Thr90Thr | synonymous_variant | Exon 4 of 23 | ENST00000242067.11 | NP_940820.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000549 AC: 8AN: 145774Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
8
AN:
145774
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000603 AC: 15AN: 248866 AF XY: 0.0000743 show subpopulations
GnomAD2 exomes
AF:
AC:
15
AN:
248866
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000381 AC: 55AN: 1445462Hom.: 0 Cov.: 28 AF XY: 0.0000347 AC XY: 25AN XY: 719786 show subpopulations
GnomAD4 exome
AF:
AC:
55
AN:
1445462
Hom.:
Cov.:
28
AF XY:
AC XY:
25
AN XY:
719786
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33220
American (AMR)
AF:
AC:
4
AN:
44592
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
25986
East Asian (EAS)
AF:
AC:
1
AN:
39346
South Asian (SAS)
AF:
AC:
9
AN:
85706
European-Finnish (FIN)
AF:
AC:
0
AN:
52734
Middle Eastern (MID)
AF:
AC:
4
AN:
5742
European-Non Finnish (NFE)
AF:
AC:
30
AN:
1098344
Other (OTH)
AF:
AC:
6
AN:
59792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000549 AC: 8AN: 145774Hom.: 0 Cov.: 31 AF XY: 0.0000423 AC XY: 3AN XY: 70900 show subpopulations
GnomAD4 genome
AF:
AC:
8
AN:
145774
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
70900
show subpopulations
African (AFR)
AF:
AC:
4
AN:
39804
American (AMR)
AF:
AC:
2
AN:
14702
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3374
East Asian (EAS)
AF:
AC:
0
AN:
5036
South Asian (SAS)
AF:
AC:
1
AN:
4582
European-Finnish (FIN)
AF:
AC:
0
AN:
9912
Middle Eastern (MID)
AF:
AC:
0
AN:
304
European-Non Finnish (NFE)
AF:
AC:
1
AN:
65232
Other (OTH)
AF:
AC:
0
AN:
2002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 14, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Bardet-Biedl syndrome 9 Benign:1
Jan 11, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Bardet-Biedl syndrome Benign:1
Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.